CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
189 hedge funds and large institutions have $1.61B invested in Cymabay Therapeutics in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 52
7% more call options, than puts
Call options by funds: $35M | Put options by funds: $32.9M
Holders
189
Holding in Top 10
12
Calls
$35M
Puts
$32.9M
Top Buyers
| 1 | +$103M | |
| 2 | +$46.5M | |
| 3 | +$36.2M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$32.4M |
| 5 |
Jennison Associates
New York
|
+$28.1M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$22.3M | |
| 3 | -$22.2M | |
| 4 |
Millennium Management
New York
|
-$19.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$14.1M |